Extendicare Inc. (EXETF)
USD 7.0
(-0.71%)
USD 7.0
(-0.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 118.42 Million CAD | 54.14% |
| 2022 | 76.82 Million CAD | -49.36% |
| 2021 | 151.71 Million CAD | -23.26% |
| 2020 | 197.69 Million CAD | 111.07% |
| 2019 | 93.66 Million CAD | -4.93% |
| 2018 | 98.51 Million CAD | -5.36% |
| 2017 | 104.09 Million CAD | -20.01% |
| 2016 | 130.13 Million CAD | 1.46% |
| 2015 | 128.25 Million CAD | 18.73% |
| 2014 | 108.02 Million CAD | -53.26% |
| 2013 | 231.09 Million CAD | -10.22% |
| 2012 | 257.39 Million CAD | -4.42% |
| 2011 | 269.29 Million CAD | -16.16% |
| 2010 | 321.2 Million CAD | -5.11% |
| 2009 | 338.48 Million CAD | 15.33% |
| 2008 | 293.49 Million CAD | 2.93% |
| 2007 | 285.12 Million CAD | 39.54% |
| 2006 | 204.32 Million CAD | -31.43% |
| 2005 | 297.99 Million CAD | 23.74% |
| 2004 | 240.82 Million CAD | 17.45% |
| 2003 | 205.04 Million CAD | -88.32% |
| 2002 | 1.75 Billion CAD | 3.0% |
| 2001 | 1.7 Billion CAD | -5.69% |
| 2000 | 1.8 Billion CAD | -4.51% |
| 1999 | 1.89 Billion CAD | -10.42% |
| 1998 | 2.11 Billion CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 44.55 Million CAD | 23.09% |
| 2024 Q1 | 36.19 Million CAD | 5.67% |
| 2023 Q1 | 36.84 Million CAD | 163.96% |
| 2023 Q4 | 34.25 Million CAD | 32.74% |
| 2023 FY | 118.42 Million CAD | 54.14% |
| 2023 Q3 | 25.8 Million CAD | 23.36% |
| 2023 Q2 | 20.92 Million CAD | -43.22% |
| 2022 Q1 | 24.19 Million CAD | 338.43% |
| 2022 Q4 | 13.95 Million CAD | -12.4% |
| 2022 Q2 | 22.28 Million CAD | -7.89% |
| 2022 Q3 | 15.93 Million CAD | -28.5% |
| 2022 FY | 76.82 Million CAD | -49.36% |
| 2021 Q1 | 30.36 Million CAD | -46.09% |
| 2021 FY | 151.71 Million CAD | -23.26% |
| 2021 Q2 | 21.94 Million CAD | -27.72% |
| 2021 Q4 | -10.14 Million CAD | -146.39% |
| 2021 Q3 | 21.87 Million CAD | -0.34% |
| 2020 Q3 | 111.87 Million CAD | 97.54% |
| 2020 Q4 | 56.31 Million CAD | -49.67% |
| 2020 Q2 | 56.63 Million CAD | 82.2% |
| 2020 Q1 | 31.08 Million CAD | -5.46% |
| 2020 FY | 197.69 Million CAD | 111.07% |
| 2019 Q2 | 35.32 Million CAD | 16.24% |
| 2019 Q1 | 30.38 Million CAD | -7.54% |
| 2019 Q4 | 32.87 Million CAD | -5.71% |
| 2019 FY | 93.66 Million CAD | -4.93% |
| 2019 Q3 | 34.86 Million CAD | -1.28% |
| 2018 Q1 | 29.32 Million CAD | -17.69% |
| 2018 FY | 98.51 Million CAD | -5.36% |
| 2018 Q2 | 36.3 Million CAD | 23.82% |
| 2018 Q3 | 35.49 Million CAD | -2.24% |
| 2018 Q4 | 32.86 Million CAD | -7.41% |
| 2017 Q4 | 35.62 Million CAD | 2.57% |
| 2017 Q1 | 31.6 Million CAD | -6.37% |
| 2017 Q2 | 33.86 Million CAD | 7.16% |
| 2017 FY | 104.09 Million CAD | -20.01% |
| 2017 Q3 | 34.72 Million CAD | 2.55% |
| 2016 FY | 130.13 Million CAD | 1.46% |
| 2016 Q4 | 33.75 Million CAD | -3.67% |
| 2016 Q2 | 34.74 Million CAD | -86.04% |
| 2016 Q3 | 35.04 Million CAD | 0.84% |
| 2016 Q1 | 248.92 Million CAD | 626.08% |
| 2015 FY | 128.25 Million CAD | 18.73% |
| 2015 Q4 | 34.28 Million CAD | -1.4% |
| 2015 Q2 | 33.38 Million CAD | 29.34% |
| 2015 Q1 | 25.81 Million CAD | 102.68% |
| 2015 Q3 | 34.77 Million CAD | 4.14% |
| 2014 FY | 108.02 Million CAD | -53.26% |
| 2014 Q4 | -963.48 Million CAD | -369.87% |
| 2014 Q3 | 357.01 Million CAD | 422.75% |
| 2014 Q2 | 68.29 Million CAD | 26.12% |
| 2014 Q1 | 54.15 Million CAD | 7.19% |
| 2013 Q3 | 61.95 Million CAD | 2.39% |
| 2013 FY | 231.09 Million CAD | -10.22% |
| 2013 Q4 | 50.51 Million CAD | -18.46% |
| 2013 Q2 | 60.51 Million CAD | 4.12% |
| 2013 Q1 | 58.11 Million CAD | -88.31% |
| 2012 Q4 | 497.03 Million CAD | 779.43% |
| 2012 Q2 | 62.36 Million CAD | -4.91% |
| 2012 FY | 257.39 Million CAD | -4.42% |
| 2012 Q1 | 65.58 Million CAD | 27.18% |
| 2012 Q3 | 56.51 Million CAD | -9.38% |
| 2011 Q3 | 56.32 Million CAD | -33.67% |
| 2011 Q2 | 84.91 Million CAD | 7.28% |
| 2011 FY | 269.29 Million CAD | -16.16% |
| 2011 Q4 | 51.56 Million CAD | -8.44% |
| 2011 Q1 | 79.15 Million CAD | -9.27% |
| 2010 Q4 | 87.24 Million CAD | 24.55% |
| 2010 Q1 | 76.73 Million CAD | 105.88% |
| 2010 FY | 321.2 Million CAD | -5.11% |
| 2010 Q2 | 87.19 Million CAD | 13.63% |
| 2010 Q3 | 70.04 Million CAD | -19.67% |
| 2009 FY | 338.48 Million CAD | 15.33% |
| 2009 Q1 | 84.71 Million CAD | -2.11% |
| 2009 Q2 | 559.48 Million CAD | 560.47% |
| 2009 Q3 | 529.13 Million CAD | -5.43% |
| 2009 Q4 | -1.3 Billion CAD | -346.57% |
| 2008 Q1 | 67.35 Million CAD | -2.52% |
| 2008 FY | 293.49 Million CAD | 2.93% |
| 2008 Q4 | 86.53 Million CAD | 20.71% |
| 2008 Q3 | 71.68 Million CAD | 4.07% |
| 2008 Q2 | 68.88 Million CAD | 2.27% |
| 2007 FY | 285.12 Million CAD | 39.54% |
| 2007 Q3 | 70.14 Million CAD | 0.31% |
| 2007 Q4 | 69.09 Million CAD | -1.5% |
| 2007 Q2 | 69.93 Million CAD | 0.32% |
| 2007 Q1 | 69.7 Million CAD | 3032.44% |
| 2006 Q2 | 71.35 Million CAD | 11.38% |
| 2006 Q4 | -2.37 Million CAD | -103.37% |
| 2006 Q1 | 64.06 Million CAD | -4.82% |
| 2006 Q3 | 70.46 Million CAD | -1.25% |
| 2006 FY | 204.32 Million CAD | -31.43% |
| 2005 Q2 | 87.79 Million CAD | 33.3% |
| 2005 Q1 | 65.86 Million CAD | 17.79% |
| 2005 FY | 297.99 Million CAD | 23.74% |
| 2005 Q3 | 75.6 Million CAD | -13.88% |
| 2005 Q4 | 67.3 Million CAD | -10.97% |
| 2004 Q1 | 55.11 Million CAD | 0.61% |
| 2004 Q4 | 55.91 Million CAD | -15.97% |
| 2004 Q3 | 66.54 Million CAD | 5.2% |
| 2004 FY | 240.82 Million CAD | 17.45% |
| 2004 Q2 | 63.25 Million CAD | 14.78% |
| 2003 Q1 | 44.24 Million CAD | 0.0% |
| 2003 FY | 205.04 Million CAD | -88.32% |
| 2003 Q3 | 55.52 Million CAD | 9.95% |
| 2003 Q4 | 54.77 Million CAD | -1.34% |
| 2003 Q2 | 50.49 Million CAD | 14.13% |
| 2002 FY | 1.75 Billion CAD | 3.0% |
| 2001 FY | 1.7 Billion CAD | -5.69% |
| 2000 FY | 1.8 Billion CAD | -4.51% |
| 1999 FY | 1.89 Billion CAD | -10.42% |
| 1998 FY | 2.11 Billion CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | -1160.181% |
| Arem Pacific Corporation | 239.16 Thousand USD | -49417.482% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | -16525.44% |
| BioCorRx Inc. | 53.17 Thousand USD | -222615.989% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | -11863.81% |
| Banyan Corp. | 5 Million USD | -2266.793% |
| Clearday, Inc. | -6.84 Million USD | 1828.963% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -3550.306% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -10789433.623% |
| Empower Clinics Inc. | 1.96 Million USD | -5917.562% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 971131.486% |
| Selectis Health, Inc. | 5.4 Million USD | -2090.202% |
| Ethema Health Corporation | 4.66 Million USD | -2436.542% |
| HealthLynked Corp. | 2.34 Million USD | -4942.105% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | -1645.528% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | -24416.459% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 17.586% |
| MedSmart Group Inc. | -19.03 Thousand USD | 622155.888% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -161561.843% |
| Nova Leap Health Corp. | 9.76 Million USD | -1112.351% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -33576.275% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -1027.695% |
| Raffles Medical Group Ltd | 239.4 Million USD | 50.533% |
| Ryman Healthcare Limited | 260.65 Million USD | 54.565% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 9877.166% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 193554.433% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 592235.0% |
| Veltex Corporation | 694.58 Thousand USD | -16950.013% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -40165.269% |